References

Conducting a study on the international implementation of services & products

Project outline

  • To achieve its strategic ambition, the R&D department of this medical diagnostic company (haemostasis tests) wishes to study the implementation, at the international level, of new services and products for patients and medical staff.
  • Pagamon supports them in the realization of this study, in addition to the current diagnostic and clinical approach.

PROJECT APPROACH

  • This framing of the innovation is structured in 4 areas of analysis:
    • Strategy: IVD (in vitro diagnosis) market trends, summary of the laboratory’s strategic ambition.
    • External needs: identification and analysis of requests from clinicians, biologists, and patients.
    • Avenues of reflection: identification and analysis of key areas of attention.
    • Possible options for all the company’s key departments.

RESULTS

  • 15 interviews and 3 scoping meetings allowed us to:
    • Identify the major needs of the IVD market and of the company (collection and analysis of internal needs, analysis of the IVD market).
    • Analyze and validate the needs of new medical services to users.
    • Investigate all avenues of thought, soliciting both internal and external expertise.
    • Identify possible implementation options and develop a SWOT analysis.
    • Build and share the study file.

Pagamon is a strategy and transformation consulting firm founded in 2013. We support major players in the industry, services and life sciences sectors in their search for balance. Helping them structure their strategic vision, transform their operational and/or digital model, and drive change. To support profitable, sustainable and responsible growth. As a committed player, Pagamon leads the Observatory of the Balanced Organization™, articulated around a "think tank" and an annual survey. In order to provide an innovative, sometimes offbeat, perspective on the strategic and operational implementation of transformations to support the growth of companies.